Literature DB >> 26260238

Binding interaction of SGLT with sugar and thiosugar by the molecular dynamics simulation.

Yunoshin Tamura1, Hiroh Miyagawa1, Tatsusada Yoshida2, Hiroshi Chuman3.   

Abstract

The human sodium-glucose co-transporter 2 (hSGLT2) is a transporter responsible for reabsorption of glucose in the proximal convoluted tubule of the kidney. hSGLT2 inhibitors, including luseogliflozin, have been developed as drugs for type 2 diabetes mellitus. Only luseogliflozin contains a thiosugar ring in its chemical structure, while other hSGLT2 inhibitors contain glucose rings. Consequently, we focused on the binding interactions of hSGLT2 with sugars and thiosugars. We first revealed that the binding affinities of thiosugars are stronger than those of sugars through molecular dynamics simulations of Vibrio parahaemolyticus, sodium-galactose co-transporter, and human hSGLT2. We then demonstrated that Na(+) dissociates from the protein to the cytoplasmic solution more slowly in the thiosugar system than in the sugar system. These differences between sugars and thiosugars are discussed on the basis of the different binding modes due to the atom at the 5-position of the sugar and thiosugar rings. Finally, as a result of Na(+) dissociation, we suggest that the dissociation of thiosugars is slower than that of sugars.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Bennett's acceptance ratio method; Binding free energy; Co-transporter; Luseogliflozin; Molecular dynamics

Mesh:

Substances:

Year:  2015        PMID: 26260238     DOI: 10.1016/j.bbamem.2015.08.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  2 in total

Review 1.  Transient Sulfenic Acids in the Synthesis of Biologically Relevant Products.

Authors:  Anna Barattucci; Maria Chiara Aversa; Aurora Mancuso; Tania Maria Grazia Salerno; Paola Bonaccorsi
Journal:  Molecules       Date:  2018-04-27       Impact factor: 4.411

2.  Polypharmacology of clinical sodium glucose co-transport protein 2 inhibitors and relationship to suspected adverse drug reactions.

Authors:  Karan Matharu; Kiran Chana; Charles J Ferro; Alan M Jones
Journal:  Pharmacol Res Perspect       Date:  2021-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.